Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Return on Assets (2016 - 2025)

Historic Return on Assets for ImmunityBio (IBRX) over the last 11 years, with Q3 2025 value amounting to 0.76%.

  • ImmunityBio's Return on Assets rose 7000.0% to 0.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year increase of 7000.0%. This contributed to the annual value of 0.93% for FY2024, which is 4100.0% up from last year.
  • As of Q3 2025, ImmunityBio's Return on Assets stood at 0.76%, which was up 7000.0% from 1.04% recorded in Q2 2025.
  • In the past 5 years, ImmunityBio's Return on Assets ranged from a high of 0.76% in Q3 2025 and a low of 1.49% during Q2 2023
  • In the last 5 years, ImmunityBio's Return on Assets had a median value of 1.22% in 2023 and averaged 1.2%.
  • As far as peak fluctuations go, ImmunityBio's Return on Assets plummeted by -4300bps in 2023, and later surged by 7000bps in 2025.
  • Over the past 5 years, ImmunityBio's Return on Assets (Quarter) stood at 1.02% in 2021, then decreased by -14bps to 1.17% in 2022, then decreased by -7bps to 1.25% in 2023, then increased by 11bps to 1.11% in 2024, then skyrocketed by 32bps to 0.76% in 2025.
  • Its Return on Assets stands at 0.76% for Q3 2025, versus 1.04% for Q2 2025 and 1.19% for Q1 2025.